Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68,438 | -40,160 | -103,639 | -75,430 | -52,142 |
| Depreciation Amortization | 1,921 | 965 | 4,071 | 3,163 | 2,153 |
| Accounts payable and accrued liabilities | -641 | 9,809 | 95 | -3,730 | -2,342 |
| Other Working Capital | -265 | 9,923 | 711 | -5,770 | -4,130 |
| Other Operating Activity | 19,876 | -6,719 | 8,652 | 10,344 | 6,231 |
| Operating Cash Flow | $-47,547 | $-26,182 | $-90,110 | $-71,423 | $-50,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -169 | -105 | -2,376 | -1,760 | -1,056 |
| Purchase Of Investment | -67,937 | N/A | -123,857 | -123,857 | -99,782 |
| Sale Of Investment | 68,260 | 33,200 | 140,501 | 120,291 | 89,523 |
| Investing Cash Flow | $154 | $33,095 | $14,268 | $-5,326 | $-11,315 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 17,116 | 17,116 | 17,116 |
| Debt Repayment | -94 | -47 | -17,438 | -17,573 | -17,527 |
| Common Stock Issued | 84,294 | 1,420 | 54,302 | 54,292 | 54,291 |
| Other Financing Activity | 0 | 0 | -181 | 0 | 0 |
| Financing Cash Flow | $84,200 | $1,373 | $53,799 | $53,835 | $53,880 |
| Beginning Cash Position | 24,340 | 24,340 | 46,383 | 46,383 | 46,383 |
| End Cash Position | 61,147 | 32,626 | 24,340 | 23,469 | 38,718 |
| Net Cash Flow | $36,807 | $8,286 | $-22,043 | $-22,914 | $-7,665 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,547 | -26,182 | -90,110 | -71,423 | -50,230 |
| Capital Expenditure | -206 | -142 | -2,451 | -1,760 | -1,056 |
| Free Cash Flow | -47,753 | -26,324 | -92,561 | -73,183 | -51,286 |